StockTipsArenaBeta

Dr. Reddy's Laboratories Share price target & analyst calls

Sector:Pharmaceuticals & Biotechnology
₹1,233.3-5.70 (-0.46%)

Avg 1-year target

13 of 19 long-term calls BUY

₹1,345.719.1% above today's price

Dr. Reddy's Laboratories' average 1-year share price target is ₹1,345.71, the average of 14 advisors' latest targets. Targets range from ₹1,040 to ₹1,740.

Latest: Macquarie ₹1,375 · 7 Oct 2026

26
20 BUY · 6 SELL, all horizons
14
with an active 1Y target
35%
24 of 69 closed calls hit
95
all horizons, open and closed
Watch DRREDDY for new buy/sell callsGet alertsSee 43 Pharmaceuticals & Biotechnology sector analyst picks

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

Dr. Reddy's Laboratories target price by brokerage

Each advisor's latest 1-year target · 14 advisors · tap a row for the call

All tips (95)

BUYTarget₹1,375
MbyMacquarie+11.5% to target
1 Year* · 12 mo left · 7 Oct 2026 · entry ₹1,208 · via Zee Business (Live)P&L +2.1%
BUYTarget₹1,450
CbyCitigroup+17.6% to target
1 Year · 11 mo left · 29 Sept 2026 · entry ₹1,243.2 · via Zee Business (Live)P&L -0.8%
BUYTarget₹1,300
SMbySomil Mehta, Sharekhan+5.4% to target
1 Year · 11 mo left · 18 Sept 2026 · entry ₹1,194.9 · via NDTV ProfitP&L +3.2%
BUYTarget₹1,365
NWbyNuvama Wealth+10.7% to target
1 Year* · 9 mo left · 23 Jul 2026 · entry ₹1,156.8 · via Financial Express MarketP&L +6.6%
SELLTarget₹1,040
CbyCitigroup+15.7% to target
1 Year* · 9 mo left · 23 Jul 2026 · entry ₹1,146.7 · via ET Now (Live)P&L -7.6%
SELLTarget₹1,070
ASbyAxis Securities+13.2% to target
1 Year* · 9 mo left · 23 Jul 2026 · entry ₹1,166.3 · via Institutional / Brokerage ResearchP&L -5.7%
BUYTarget₹1,340
ISbyICICI Securities+8.7% to target
1 Year* · 9 mo left · 23 Jul 2026 · entry ₹1,166.3 · via Institutional / Brokerage ResearchP&L +5.7%
SELLTarget₹1,100
JMbyJ.P. Morgan+10.8% to target
1 Year* · 9 mo left · 23 Jul 2026 · entry ₹1,101 · via Zee Business (Live)P&L -12.0%
SELLTarget₹1,050
GSbyGoldman Sachs+14.9% to target
1 Year* · 9 mo left · 23 Jul 2026 · entry ₹1,101 · via ET Now (Live)P&L -12.0%
BUYTarget₹1,480
BObyBank of America+20.0% to target
1 Year* · 9 mo left · 23 Jul 2026 · entry ₹1,101 · via NDTV Profit (Live)P&L +12.0%
BUYTarget₹1,460
HSbyHSBC Securities+18.4% to target
1 Year* · 9 mo left · 10 Jul 2026 · entry ₹1,247 · via CNBC Awaaz.P&L -1.1%
BUYTarget₹1,570
CbyCLSA+27.3% to target
1 Year* · 9 mo left · 10 Jul 2026 · entry ₹1,244.9 · via Zee Business (Live)P&L -0.9%
SELLTarget₹1,040
JIbyJefferies India+15.7% to target
1 Year* · 9 mo left · 9 Jul 2026 · entry ₹1,349 · via CNBC Awaaz.P&L +8.6%
BUYTarget₹1,740
NIbyNomura India Research+41.1% to target
1 Year · 8 mo left · 22 Jun 2026 · entry ₹1,298 · via NDTV Profit (Live)P&L -5.0%
BUYTarget₹1,460
ISbyICICI Securities+18.4% to target
1 Year* · 7 mo left · 13 May 2026 · entry ₹1,265.3 · via Institutional / Brokerage ResearchP&L -2.5%
SELLTarget₹1,070
CbyCitigroup+13.2% to target
1 Year* · 6 mo left · 15 Apr 2026 · entry ₹1,217.8 · via ET NowP&L -1.3%
BUYTarget₹1,490
ISbyICICI Securities+20.8% to target
1 Year* · 3 mo left · 23 Jan 2026 · entry ₹1,235.6 · via Institutional / Brokerage ResearchP&L -0.2%
BUYTarget₹1,500
BCbyBOB Capital Markets+21.6% to target
1 Year* · 3 mo left · 22 Jan 2026 · entry ₹1,217.5 · via Institutional / Brokerage ResearchP&L +1.3%
BUYTarget₹1,510
ISbyICICI Securities+22.4% to target
1 Year* · 4d left · 27 Oct 2025 · entry ₹1,284.3 · via Institutional / Brokerage ResearchP&L -4.0%
BUYTarget₹1,240
CbyCLSATarget hit
1 Year* · 23 Jul 2026 · entry ₹1,154.7 · via CNBC Awaaz.exit ₹1,240
SELLTarget₹1,215
MSbyMorgan StanleyTarget hit
1 Year* · 10 Jul 2026 · entry ₹1,240.8 · via CNBC Awaaz.exit ₹1,215
SELLTarget₹1,300
EGbyEmkay GlobalTarget hit
1 Year* · 1 Jul 2026 · entry ₹1,339.9 · via Institutional / Brokerage Researchexit ₹1,300
SELLTarget₹1,140
DCbyDeven Choksey, DRChokseyTarget hit
1 Year* · 29 Oct 2025 · entry ₹1,289.4 · via Institutional / Brokerage Researchexit ₹1,140
SELLTarget₹1,200
EGbyEmkay GlobalTarget hit
1 Year* · 26 Oct 2025 · entry ₹1,283.6 · via Institutional / Brokerage Researchexit ₹1,200
SELLTarget₹1,120
DCbyDeven Choksey, DRChokseyTarget hit
1 Year* · 29 Jul 2025 · entry ₹1,287.4 · via Institutional / Brokerage Researchexit ₹1,120
SELLTarget₹1,150
GFbyGeojit Financial ServicesTarget hit
1 Year* · 7 Jul 2025 · entry ₹1,310.5 · via Institutional / Brokerage Researchexit ₹1,150
SELLTarget₹1,150
EGbyEmkay GlobalTarget hit
1 Year* · 24 Jan 2025 · entry ₹1,224.4 · via Institutional / Brokerage Researchexit ₹1,150
SELLTarget₹1,070
EGbyEmkay GlobalTarget hit
1 Year* · 6 Nov 2024 · entry ₹1,302.1 · via Institutional / Brokerage Researchexit ₹1,070
SELLTarget₹6,000⚙︎
PLbyPrabhudas LilladherTarget hit
1 Year* · 29 Jul 2024 · entry ₹6,840.05 · via Institutional / Brokerage Researchexit ₹6,000
SELLTarget₹6,350⚙︎
ISbyICICI SecuritiesTarget hit
1 Year* · 28 Jul 2024 · entry ₹6,878.65 · via Institutional / Brokerage Researchexit ₹6,350
SELLTarget₹5,700⚙︎
PLbyPrabhudas LilladherTarget hit
1 Year* · 8 May 2024 · entry ₹6,056.35 · via Institutional / Brokerage Researchexit ₹5,700
BUYTarget₹6,537⚙︎
SRbySharekhan ResearchTarget hit
1 Year* · 1 Apr 2024 · entry ₹6,237.55 · via Institutional / Brokerage Researchexit ₹6,537
BUYTarget₹1,500
JTbyJay Thakkar, ICICI SecuritiesStop-loss hit
1 Year* · 7 Jul 2026 · entry ₹1,364 · via Business Todayexit ₹1,280
BUYTarget₹1,450
ASbyAxis SecuritiesExpired
1 Year* · 24 Jan 2025 · entry ₹1,224.4 · via Institutional / Brokerage Researchexit ₹1,235.6
BUYTarget₹1,535
ASbyAxis SecuritiesExpired
1 Year* · 6 Nov 2024 · entry ₹1,302.1 · via Institutional / Brokerage Researchexit ₹1,205.2
BUYTarget₹1,570
ISbyICICI SecuritiesExpired
1 Year* · 6 Nov 2024 · entry ₹1,302.1 · via Institutional / Brokerage Researchexit ₹1,205.2
BUYTarget₹1,300
AAbyAditya Agarwal, Coheron Brokers+5.4% to target
1–3 Months · 8 wk left · 21 Sept 2026 · entry ₹1,200 · via Business TodayP&L +2.8%
BUYTarget₹1,260
OKbyOsho Krishan, Angel One+2.2% to target
1–3 Months* · 3 wk left · 11 Aug 2026 · entry ₹1,202.1 · via ET Now (Live)P&L +2.6%
BUYTarget₹1,280
OKbyOsho Krishan, Angel One+3.8% to target
1–3 Months* · 11d left · 3 Aug 2026 · entry ₹1,167.1 · via NDTV ProfitP&L +5.7%
BUYTarget₹1,230
SMbySomil Mehta, SharekhanTarget hit
1–3 Months* · 17 Sept 2026 · entry ₹1,177.8 · via CNBC Awaaz.exit ₹1,230
BUYTarget₹1,285
AAbyAmol Athawale, Kotak SecuritiesStop-loss hit
1–3 Months · 28 Sept 2026 · entry ₹1,229.8 · via Zee Business (Live)exit ₹1,200
BUYTarget₹1,470
SMbySomil Mehta, SharekhanStop-loss hit
1–3 Months* · 29 Jun 2026 · entry ₹1,381.5 · via Zee Business (Live)exit ₹1,250
BUYTarget₹1,310
AKbyArun Kumar MantriStop-loss hit
1–3 Months* · 5 Jun 2026 · entry ₹1,282 · via CNBC Awaaz.exit ₹1,269
BUYTarget₹1,340
AAbyAditya Agarwal, Coheron Brokers+8.7% to target
1–2 Weeks* · 12d left · 22 Oct 2026 · entry ₹1,244.6 · via Business TodayP&L -0.9%
BUYTarget₹1,290
OKbyOsho Krishan, Angel One+4.6% to target
1–2 Weeks · 12d left · 22 Oct 2026 · entry ₹1,216.7 · via NDTV Profit (Live)P&L +1.4%
BUYTarget₹1,310
AMbyAjit Mishra, Religare+6.2% to target
1–2 Weeks · 10d left · 19 Oct 2026 · entry ₹1,240.1 · via NDTV Profit (Live)P&L -0.5%
BUYTarget₹1,365
SBbySumeet Bagadia, Choice Broking+10.7% to target
1–2 Weeks* · 10d left · 17 Oct 2026 · entry ₹1,232 · via LiveMint MarketsP&L +0.1%
BUYTarget₹1,245
CTbyChandan Taparia, Motilal OswalTarget hit
1–2 Weeks* · 12 Oct 2026 · entry ₹1,200 · via CNBC Awaaz.exit ₹1,245
BUYTarget₹1,250
ABbyAshish Bahety, Profitmart SecuritiesTarget hit
1–2 Weeks* · 29 Sept 2026 · entry ₹1,243.2 · via CNBC Awaaz.exit ₹1,250
BUYTarget₹1,220
ASbyAmit SethTarget hit
1–2 Weeks* · 21 Sept 2026 · entry ₹1,197.2 · via CNBC Awaaz.exit ₹1,220

* Horizon not stated by the source; assumed from how far the target is from the entry price.

Full call history, all horizons: page 2 of 2

Compare Pharmaceuticals & Biotechnology targets

Most-covered stocks in the sector · average 1-year target

See all Pharmaceuticals & Biotechnology analyst picks